ALTERATIONS IN METABOLIC ACTIVITY OF PLASMA LIPOPROTEINS FOLLOWING SELECTIVE CHEMICAL MODIFICATION OF THE APOPROTEINS
ALTERATIONS IN METABOLIC ACTIVITY OF PLASMA LIPOPROTEINS FOLLOWING SELECTIVE CHEMICAL MODIFICATION OF THE APOPROTEINS
复制标题
脱氧蛋白选择性化学修饰后血浆脂蛋白代谢活性的变化
DOI:
--
复制
发表时间:
1980
影响因子:
5.2
通讯作者:
K. Weisgraber
中科院分区:
文献类型:
--
作者:
R. Mahley;T. Innerarity;K. Weisgraber
Identification of the sites within the body and elucidation of the mechanisms responsible for the uptake and catabolism of the plasma lipoproteins and their cholesterol remain important questions which need to be studied. Control of lipoprotein catabolism has important implications for lipid metabolism and atherogenesis. It is now established that different cell types (fibroblasts, leukocytes, hepatocytes, adrenal cortical cells, and others) are capable of interacting with specific plasma lipoproteins. In studying these processes, our attention has been focused on the protein moieties of the lipoproteins as the determinants responsible for the interaction with cells. These studies have relied on the use of various plasma lipoproteins which have specific lipid and apoprotein constituents. Low-density lipoproteins (LDL) from various species, including man, contain almost exclusively the B apoprotein. Another useful class of lipoproteins with a lipid composition and particle size similar to those of LDL has been identified in the plasma of various animals. These lipoproteins, which are related to high-density lipoproteins (HDL), are referred to as HDL, and HDL, in control and cholesterol-fed dogs, rats, and swine, respectively.1-6 The HDL, and HDL, occur, in part, in the low-density range, but are distinctly different from LDL in that they lack the B apoprotein. They contain the E and A-I apoproteins or exclusively the E apoprotein, the latter is referred to as apoE HDL,. Such lipoproteins are present in human plasma, and their concentration appears to increase after cholesterol feeding.6,' The role of specific apoproteins has been studied by comparing the metabolism, in vitro and in vivo, of these particular lipoproteins, including LDL containing the B apoprotein, HDL, containing exclusively the E apoprotein (apoE HDL,), and HDL containing primarily the A-I (or A-I and A-11) apoprotein without the E apoprotein. Selective chemical modification of lysine and arginine residues of these lipoproteins has been used to probe the nature of lipoprotein cell interactions in vitro in cultured cells and in vivo in various animals after intravenous injection.